Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Petricciani

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
In Vitro. Monograph|January 1, 1974
Bacteriophages and interferonJ C Petricciani
Regulatory Toxicology and Pharmacology : RTP|December 1, 1983
An overview of safety and regulatory aspects of the new biotechnologyJ C Petricciani
Cytotechnology|February 24, 2012
The acceptability of continuous cell lines: A personal & historical perspectiveJ C Petricciani
Developments in Biologicals|May 4, 2000
International acceptance of blood and blood productsJ C Petricciani
Lancet (London, England)|January 21, 1984
Aflatoxins not in allergenic mould extractsJ C Petricciani
Clinical Research|December 1, 1990
Disease, drugs, and delay: suggested changes for the FDAJ C Petricciani
Food and Drug Law Journal|January 1, 1996
Reinventing the biologics approval processJ C Petricciani
Developments in Biological Standardization|January 1, 1991
Regulatory philosophy and acceptability of cells for the production of biologicalsJ C Petricciani
Developments in Biological Standardization|January 1, 1989
Cells, science and healthJ C Petricciani
Annals of Internal Medicine|November 1, 1985
Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificityJ C Petricciani
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
In Vitro. Monograph|January 1, 1974
Bacteriophages and interferonJ C Petricciani
Regulatory Toxicology and Pharmacology : RTP|December 1, 1983
An overview of safety and regulatory aspects of the new biotechnologyJ C Petricciani
Cytotechnology|February 24, 2012
The acceptability of continuous cell lines: A personal & historical perspectiveJ C Petricciani
Developments in Biologicals|May 4, 2000
International acceptance of blood and blood productsJ C Petricciani
Lancet (London, England)|January 21, 1984
Aflatoxins not in allergenic mould extractsJ C Petricciani
Clinical Research|December 1, 1990
Disease, drugs, and delay: suggested changes for the FDAJ C Petricciani
Food and Drug Law Journal|January 1, 1996
Reinventing the biologics approval processJ C Petricciani
Developments in Biological Standardization|January 1, 1991
Regulatory philosophy and acceptability of cells for the production of biologicalsJ C Petricciani
Developments in Biological Standardization|January 1, 1989
Cells, science and healthJ C Petricciani
Annals of Internal Medicine|November 1, 1985
Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificityJ C Petricciani
Pageof 10